GRI Bio Inc NASDAQ GRI to Participate in the Virtual Investor Summer Spotlight Series GRI Bio NASDAQGRI

LA JOLLA, CA, July 05, 2023 (GLOBE NEWSWIRE) — GRI Bio, Inc. GRI (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that Marc Hertz, Ph.D., President and Chief…Read More